Evidence map›Paper›PMID 33228807›Full record

ArticleTrials2020

UVR-sensor wearable device intervention to improve sun behaviors and reduce sunburns in melanoma survivors: study protocol of a parallel-group randomized controlled trial.

Rachel I Vogel, Rebekah H Nagler, Rehana L Ahmed, Katherine Brown, Xianghua Luo, Brian C Martinson, DeAnn Lazovich

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in Trials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03927742 (Wearable Device Intervention to Improve Sun Behaviors in Melanoma Survivors), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03927742 nacompletednot on this map

Wearable Device Intervention to Improve Sun Behaviors in Melanoma Survivors

TypeinterventionalSponsorUniversity of MinnesotaRan2020 to 2022Enrolled368ConditionsMelanoma (Skin)ArmsShade + app with messaging, Shape + app without messaging
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rachel I VogelDepartment of Obstetrics, Gynecology and Women's Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN, USA. isak0023@umn.edu.ORCID http://orcid.org/0000-0003-0149-8464
Rebekah H NaglerMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Rehana L AhmedMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Katherine BrownDepartment of Obstetrics, Gynecology and Women's Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN, USA.
Xianghua LuoMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Brian C MartinsonHealthPartners Institute, Bloomington, MN, USA.
DeAnn LazovichMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
University of Minnesota · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
American Cancer Society 133512-RSG-19-014-01-CPPBMelanoma Research Alliance 568166NCATS NIH HHS UL1 TR002494NCATS NIH HHS UL1TR002494NCI NIH HHS P30 CA077598NCI NIH HHS P30 CA77598
6 · The paper itself

Abstract

backgroundIndividuals who have been diagnosed with melanoma have more than a 9-fold increased risk of developing another melanoma. Ultraviolet radiation (UVR) exposure following a melanoma diagnosis can be modified to reduce risk of a new melanoma diagnosis. Yet research shows that many melanoma survivors do not report optimal sun protection practices. The objective of this study is to evaluate the effectiveness of a UVR-sensor wearable device to improve sun protection behaviors and reduce sunburns in a randomized controlled trial (RCT) in melanoma survivors.

methodsWe will conduct an RCT among 368 melanoma survivors in two waves (Summer 2020, Summer 2021). This approach allows for adequate recruitment of the required sample and potential improvements to recruitment, compliance, and retention strategies between waves. The intervention includes an informational brochure about sun protection behaviors and a commercially available UVR-sensor wearable device (Shade), which accurately measures UVR. The device, along with its associated mobile application, measures and stores UVR exposure. As UVR exposure accumulates, the device provides notifications to increase sun protection action. Survivors in the control group receive the device and a separate mobile application that does not provide notifications or summary UVR exposure data. Participants will be asked to wear the device for 12 weeks. They will complete surveys about their sun behaviors at study entry, every 4 weeks during the intervention, and 1 year later. At the end of the intervention period, intervention and control groups will be compared for differences in a summary measure of sun protection habits and experience of a sunburn. We will also measure self-reported physical activity, depression, and anxiety to examine potential unintended negative consequences of the intervention. DISCUSSION: The study intervention will be completed Fall 2021, with anticipated results available in 2022. If this intervention improves sun protection behaviors in melanoma survivors, these findings would support expanding the use of this technology with other populations at high risk for melanoma.

trial registrationClinicalTrials.gov NCT03927742 . Registered on April 15, 2019.

Indexed as

MelanomaSkin NeoplasmsSunburnWearable Electronic DevicesHumansRandomized Controlled Trials as TopicSunscreening AgentsSurvivorsSunscreening AgentsCancer survivorsEcological momentary interventionMelanomaSun protectionUltraviolet exposure

Identifiers

PMID33228807
PMCPMC7682122
OpenAlexW3109152810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.